Tag: Cancer: Ovarian
Neoadjuvant Chemotherapy Use Up in Ovarian Cancer Treatment
NACT use up from 2003 to 2012; linked to shorter overall survival in stage IIIC but not stage IV disease
Oral Contraceptives May Be Cause of Drop in Ovarian CA Mortality
Rates down 16 percent in U.S., 8 percent in Canada, and 10 percent in Europe over a decade
Recs Developed for Neoadjuvant Chemo in Ovarian Cancer
Guidance provided for clinicians treating women with stage IIIC or IV epithelial ovarian cancer
Opportunistic Salpingectomy Doesn’t Impact Ovarian Reserve
No impact on change in ovarian reserve, measured by rate of decline in anti-Müllerian hormone levels
Exercise May Be Protective Against Epithelial Ovarian Cancer
Chronic inactivity linked to greater risk for the disease
Too Few Patients Receive Surgical Treatment for Ovarian Cancer
Advanced age, disease are predictors for receiving only chemo, radiation, or nothing at all
Gene Database Offers Doctors Insights Into Breast, Ovarian CA
Database includes more than 6,200 BRCA variants
Bundle of Practices Can Cut Surgical Site Infections
Implementing bundle of evidence-based practices can reduce 30-day surgical site infections
Hormone Tx No Harm After Nonserous Epithelial Ovarian CA
For women aged younger than 55 years, hormone therapy linked to improved disease-free survival
Gene Panel Test May Help Predict Ovarian Cancer Prognosis
Women with mutations in some 'DNA repair' genes may survive much longer, research shows
